News & Updates

Show Multimedia Only
Empagliflozin lowers blood pressure in T2D

Empagliflozin lowers blood pressure in T2D

12 Mar 2022

Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.

12 Mar 2022
Weight loss in T2D patients ups death risk, but lifestyle change can help

Weight loss in T2D patients ups death risk, but lifestyle change can help

06 Mar 2022

Mortality is heightened among type 2 diabetes (T2D) patients with substantial weight loss, but such risk can be attenuated by improving lifestyle quality, suggests a recent study.

06 Mar 2022